Drug Injury Watch: Fall 2012: Two Recent Medical Reports Regarding Safety Of Pradaxa, Boehringer Ing
Drug Injury Watch: Fall 2012: Two Recent Medical Reports Regarding Safety Of Pradaxa, Boehringer Ingelheim's Anticoagulation Drug Use Of Pradaxa After ACS Is Associated With Increased Rate Of Major Bleeding, And Concomitant Use Of Pradaxa With Multaq Is Contraindicated http://www.drug-injury.com/druginjurycom/2012/09/pradaxa-associated-with-increased-bleeding-after-acs-chmp-contraindicaton-multaq.html
Contributor
About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
Related Documents in Personal Injury
- Drug Injury Watch: Disturbing Information About NuvaRing Safety Found In Motions On Experts Recently
- Drug Injury Watch: Tekturna And Other Aliskiren Related Blood Pressure Medications Can Cause Renal F
- Drug Injury Watch: Intramedullary Nailing Surgery Is Successful Treatment For Patients With Femur Fr
Categories
- Articles 313
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4